AUPH Q3 2019 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$230,000-38.7% YoY

Gross Profit

-$18M-7635.2% margin

Operating Income

-$24M-10439.6% margin

Net Income

-$19M-8277.0% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+693.1%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$151M

Total Liabilities

$27M

Stockholders' Equity

$124M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$230,000	$375,000	-38.7%
Gross Profit	-$18M	-$11M	-62.9%
Operating Income	-$24M	-$14M	-70.2%
Net Income	-$19M	-$18M	-3.8%